| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 209,4 k € | +15.0% | 182,0 k € | -10.3% | 202,9 k € | -8.1% | 220,9 k € | +1.9% | 216,8 k € | +100.4% | 108,2 k € | +22.4% | 88,4 k € | +54.5% | 57,2 k € | -15.4% | 67,7 k € | +8.2% | 62,5 k € | -24.5% | 82,9 k € | +96.6% | 42,2 k € | -72.8% | 155,2 k € | |
| EBITDA | 208,7 k € | +14.7% | 181,9 k € | -10.3% | 202,8 k € | -8.2% | 220,8 k € | +1.9% | 216,7 k € | +100.3% | 108,2 k € | +22.5% | 88,3 k € | +54.6% | 57,1 k € | -15.3% | 67,4 k € | +8.0% | 62,4 k € | -24.6% | 82,8 k € | +97.3% | 41,9 k € | -72.9% | 155,0 k € | |
| Operating profit | 187,4 k € | +29.1% | 145,1 k € | -18.2% | 177,4 k € | -6.2% | 189,1 k € | +2.3% | 184,8 k € | +138.3% | 77,5 k € | +25.8% | 61,7 k € | +60.9% | 38,3 k € | -14.0% | 44,6 k € | -14.1% | 51,9 k € | -16.0% | 61,8 k € | +233.3% | 18,5 k € | -85.8% | 130,4 k € | |
| Profit/loss | 178,0 k € | +87.2% | 95,1 k € | -24.8% | 126,5 k € | -1.6% | 128,6 k € | +0.5% | 128,0 k € | +135.2% | 54,4 k € | +30.0% | 41,9 k € | +90.9% | 21,9 k € | -53.7% | 47,3 k € | +3.2% | 45,9 k € | -22.4% | 59,2 k € | +158.5% | 22,9 k € | -73.2% | 85,3 k € | |
| Equity | 728,8 k € | +23.3% | 591,0 k € | +14.1% | 517,8 k € | +31.8% | 392,9 k € | +47.8% | 265,9 k € | +90.6% | 139,5 k € | +60.9% | 86,7 k € | +86.8% | 46,4 k € | +89.7% | 24,5 k € | -0.2% | 24,5 k € | +2.1% | 24,0 k € | +3.3% | 23,3 k € | +2.2% | 22,8 k € | |
| Total assets | 780,3 k € | +19.7% | 651,7 k € | +7.1% | 608,7 k € | +32.2% | 460,4 k € | +29.8% | 354,8 k € | +42.0% | 249,9 k € | +72.2% | 145,1 k € | +55.0% | 93,6 k € | -21.9% | 119,8 k € | +58.9% | 75,4 k € | -17.0% | 90,9 k € | +38.7% | 65,6 k € | -62.0% | 172,6 k € | |
| Cash | 125,5 k € | +31.8% | 95,2 k € | -34.7% | 145,7 k € | -12.4% | 166,4 k € | -0.4% | 167,0 k € | +77.8% | 93,9 k € | +48.0% | 63,5 k € | +57.0% | 40,4 k € | -24.1% | 53,3 k € | -1.9% | 54,3 k € | -4.5% | 56,9 k € | +365.9% | 12,2 k € | -86.1% | 87,6 k € | |
| Debts | 51,5 k € | -15.1% | 60,7 k € | -33.2% | 90,9 k € | +34.6% | 67,5 k € | -24.1% | 88,9 k € | -19.4% | 110,4 k € | +89.1% | 58,4 k € | +23.7% | 47,2 k € | -50.5% | 95,4 k € | +87.3% | 50,9 k € | -23.8% | 66,8 k € | +57.9% | 42,3 k € | -71.8% | 149,8 k € | |
Private limited company · Hooglede · incorporated on 25/03/1994
Private limited company profitable and well capitalised. Cash position rising (+31.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER PIETER NEVEJAN is a Private limited company incorporated in 1994. Its main activity is: General medical practice activities. Its registered office is in Hooglede.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette